Cardiac Pathways Overview

  • Founded
  • 1991
Founded
  • Status
  • Acquired/​Merged
  • Latest Deal Type
  • M&A
  • Latest Deal Amount
  • $115M
Latest Deal Amount

Cardiac Pathways General Information

Description

Provider of invasive systems used by electrophysiologists to diagnose and treat abnormally rapid heart rhythms. The company's products consist of systems for performing nonsurgical, minimally invasive techniques for neutralizing heart tissues responsible for starting tachyarrhythmia.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Primary Industry
Diagnostic Equipment
Acquirer
Boston Scientific
Primary Office
  • 995 Benecia Avenue
  • Sunnyvale, CA 94085
  • United States
+1 (408) 000-0000
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Cardiac Pathways Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
9. Merger/Acquisition 06-Aug-2001 $115M 00000 00000 Completed Generating Revenue
8. PIPE 26-Dec-2000 000.00 00000 Completed Generating Revenue
7. IPO 01-Jun-1996 000.00 000.00 Completed Startup
6. Later Stage VC (Series F) 01-Dec-1995 000.00 000.00 000.00 Completed Startup
5. Later Stage VC (Series E) 16-May-1994 00.00 0000 000.00 Completed Startup
4. Later Stage VC (Series D) 29-Oct-1993 0000 000.00 000.00 Completed Startup
3. Later Stage VC (Series C) 00.000 000.00 000.00 Completed Startup
2. Early Stage VC (Series B) $3.41M $3.94M 00.000 Completed Startup
1. Early Stage VC (Series A) $533K $533K 00.000 Completed Startup
To view Cardiac Pathways’s complete valuation and funding history, request access »

Cardiac Pathways Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series F 000,000 00.000000 00.0 000 000 00 000 00.000
Series E 000,000 00.000000 00.00 000.00 000.00 00 000.00 0.000
Series D 0,000,000 00.000000 00.00 00.0 00.0 00 00.0 00.00
Series C 0,000,000 00.000000 00.00 00 00 00 00 00.000
Series B 1,514,445 $0.001000 $0.18 $2.25 $2.25 1x $2.25 23.02%
Series A 716,667 $0.001000 $0.06 $0.75 $0.75 1x $0.75 10.79%
To view Cardiac Pathways’s complete cap table history, request access »

Cardiac Pathways Executive Team (3)

Name Title Board Seat Contact Info
Thomas Prescott President & Chief Executive Officer
Joseph Gorman Chief Investment Officer
Mir Imran Founder & Director
To view Cardiac Pathways’s complete executive team members history, request access »

Cardiac Pathways Former Investors (13)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Delphi Ventures Venture Capital Minority 000 0000 000000 0
Faria Fund Minority 000 0000 000000 0
Fogarty Family Revocable Trust Minority 000 0000 000000 0
IVP Venture Capital Minority 000 0000 000000 0
MedVenture Associates Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 13 investors. Get the full list »